OMAHA, Neb. – Transgenomic, Inc. (OTC/BB: TBIO) today announced that it has entered into a Convertible Promissory Note Purchase Agreement (the “Purchase Agreement”) in the aggregate amount of $3.0 million with entities (the “Investors”) associated with Third Security, LLC, a leading life sciences investment firm. “We are very pleased with the additional investment by Third [...]

IRVINE, Calif. and AMSTERDAM -- Agendia, an innovative molecular cancer diagnostics company, today announced that the company has signed a contract with Blue Shield of California, making Agendia an in-network provider. The move paves the way for future in-network coverage for MammaPrint® and other Agendia tests by Blue Cross affiliates across the United States. Developed [...]

TUCSON, Ariz.--BioVigilant Systems, Inc. (www.biovigilant.com), inventors of Instantaneous Microbial Detection™, announced today that it has changed its name to Azbil BioVigilant, Inc. The name change reflects the Company’s alignment with its corporate parent, Yamatake Corporation of the azbil Group, to focus its 47 subsidiaries and affiliates around a common philosophy of “human-centered automation.” “Since Yamatake’s [...]

CARLSBAD, Calif.-- Life Technologies Corporation (NASDAQ: LIFE) has received validation from the certification body of Association Francaise de Normalisation (AFNOR) for its MicroSEQ® Listeria spp. and MicroSEQ® Listeria monocytogenes assays, molecular tests that are designed to quickly and accurately detect the presence or absence of this food-borne pathogen that most recently has been associated with [...]

Hamburg/Juelich - Eppendorf AG today announced its acquisition of the DASGIP Group, a technology leader in the fields of bioprocess and information technology. DASGIP, with offices in Juelich, Germany, and Shrewsbury, Massachusetts, has established a high reputation as developer and manufacturer of parallel bioreactor systems and innovative control and analysis software. Eppendorf CEO Dirk Ehlers, [...]

Today Bioo Scientific announced the launch of the NEXTflex™ DNA, ChIP-Seq, and PCR-Free Modules offering increased flexibility to NGS library preparation. Modules are available for each step in the library preparation protocol including end repair, adenylation, ligation and PCR. These new products include enzymes, buffers and protocols for NGS library construction. The reagents are suitable [...]

PROVIDENCE, R.I. -- Nabsys, Inc., has initiated its transition from technology development to product commercialization by announcing the appointment of Stan Rose, Ph.D., as the company's first chief commercial officer. Nabsys is also announcing that Jeffrey Sklar, M.D., Ph.D., has agreed to join the company's scientific advisory board. Nabsys is pioneering the development of a [...]

Pleasanton, California – IntegenX Inc. today announced the launch of mygentegra.com, an e-commerce and information web site for researchers concerned about the economic and environmental costs of traditional freezer-based DNA and RNA sample storage. Researchers exploring current concepts and technologies for nucleic acid storage will find peer-reviewed publications, academic posters, videos, and technical information on [...]

Charlottesville, VA – ZyGEM Corp. Ltd., a developer and marketer of innovative products for the analysis of DNA and other nucleic acids, and the US Army Medical Research Institute of Infectious Diseases (USAMRIID), today announced the signing of a Cooperative Research and Development Agreement (CRADA) for the development of simplified sample processing solutions for biothreat [...]

CAMBRIDGE, Mass. -- Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array (SiMoA™) technology, announced today a strategic investment and technology development agreement with In-Q-Tel (IQT), the independent strategic investment firm that identifies innovative technology solutions to support the missions of the U.S. Intelligence Community. [...]